Introduction: Sinusitis is a serious health hazard that is caused by inflammation of the surrounding sinus. Bacterial infection due to Streptococcus pneumonia microorganisms, Haemophilus influenza, Moraxella catarrhalis and Staphylococcus aureus is one of the factors causing sinusitis and bronchitis. Medicago sativa is known as a precious medicinal plant. The purpose of this study is to investigate the antibacterial effect of Medicago sativa extract on common bacteria in sinusitis and bronchitis. Methods: In this experimental study, after root extraction of the plant by maceration method, first the quantitative Minimum Inhibitory growth Concentration (MIC) test was carried out and then disc diffusion quality test was performed with the observance of standard strains for Streptococcus pneumonia, Haemophilus influenza, Moraxella catarrhalis, and Staphylococcus aureus.
Introduction
inusitis is a serious threat to human health, and the social and economic burden imposes heavy costs on the affected person and the community (1) .
Sinusitis is the inflammation of sinuses around nose, the causes of which can be infections, allergic reactions, as well as self-contained disorders. Bacterial sinusitis is divided into two acute and chronic groups, each of which runs its own path (2) .
Bronchitis is associated with the inflammation of bronchus, with symptoms such as choking, coughing, and phlegm (3) . Approximately, 75% of outpatient visits to physicians who need antibiotics are due to sinusitis and bronchitis. The isolated bacterial agents from most of these patients include Streptococcus pneumoniae, Haemophilus influenza, Moraxella catarrhalis and Staphylococcus aureus (4) (5) (6) . Sinusitis treatment involves removing predisposing factors (allergic rhinitis, immunodeficiency, diabetes, depression of the nasal septum, nasal congestion, concha bullous, anemia and malnutrition), nasal wash with normal saline, inside nose corticosteroid and oral antibiotics.
Cephalosporins, macrolides, and amoxiclavare common used antibiotics (7) . The improper use of antimicrobial chemicals leads to increased antibiotic resistance in most bacteria (8) . The resistance of bacteria to antibiotics is increasing day to day, which makes humans think of replacing effective antimicrobials with fewer side effects. Herbal extracts contain substances that can be used against many microorganisms. These antimicrobial effects have been demonstrated against bacteria and fungi (9). The Medicago Sativa known as alfalfa. Medicago Sativa is a medicinal plant belonging to Fabaceae family. This herb is rich from substances called saponins. Recent studies have shown that saponins produce many effects in the body that can boost the immune system, have anti-tumor effects, helps detoxification due to the combination with bile acid, as well as antimicrobial effects such as antibacterial, antifungal and also has an antiviral effect (10, 11) . In most cases, numerous scientific investigations have led to the confirmation of therapeutic value of medicinal plants. Medicago Sativa used to be known/named as the Queen of Plants and Green Gold (12) . The plant is rich in various proteins, calcium, mineral elements, various vitamins in group B, vitamins A, C, D, E, K and amylase enzyme, emulcer, invertase and pectinase, as well as very small amounts of arsenic and silica (13) (14) (15) (16) (17) . In the taste of people, there is a greater tendency to use plant compounds instead of chemical drugs. while, many researchers believe that the side effects of taking herbal drugs are much fewer than chemical drugs. Due to the wide distribution of medicinal plants in our country, studies on their antimicrobial properties provide a suitable basis for using the results of these studies to replace the natural drugs to control and treat bacterial infections. It can reduce the use of chemical drugs and their complications. In this research, the antimicrobial effects of alfalfa extract on common bacteria in sinusitis and bronchitis are investigated.
Methods

Bacterial strains In this research, bacterial strains of Streptococcus pneumonia (ATCC49619), Haemophilus influenza (ATCC35056), Moraxella catarrhalis (ATCC25240)
and Staphylococcus aureus (ATCC25923) are tested, which were prepared by Pasteur Institute.
Culture medium
Blood agar culture media, chocolate agar and Mueller hinton broth were used in this study, which were purchased from Merck, Germany.
Extract preparation
The extract used was an extract from Medicago Sativa roots which was prepared by maceration method. The roots of Medicago Sativa were obtained from Robat Karim, Tehran, Iran and confirmed by botanical experts. The roots of the plant in were kept a dark and humid environment, and then were milled. After, we weighed 100 g of the root stock powder and then added 400 CC 80% methanol to the powder and placed on a shaker at 4000 rpm for 24 hours. Next, the supernatant was removed and again 300 cc methanol was added to the residue. The solution was placed inside a refrigerator and this process was repeated three times. Then, the collected solution was coated with Buchner Funnel by means of a vacuum distillation machine by maceration method using a Hiedolph retro-device (Hiedolphcompany, Germany), at 40 ° C and 210-290 rpm. To separate water from the extract, a Lyophilized device was used and the extract was placed in the apparatus for 48 hours. After determining the dry weight of the extract, a concentration of 1000 mg/ml was prepared and the extract was stored in refrigerator for later usage.
Preparation of test microorganisms
At first, standard strains' samples were placed on blood agar and chocolate agar culture medium and the samples were kept at 37 °C for 24 hours. Subsequently, a quantitative minimum inhibitory concentration (MIC) test and a disc diffusion test for samples with Medicago Sativa extract was laid on Mueller hinton broth medium.
Determination of Minimum Inhibitory Concentration
After preparing the microbial suspension using the medium of the Mueller hinton broth according to the McFarland standards, a diluted equivalent (1000 mg / ml) of the extract was obtained using sterilized distilled water (18) . Next 0.5 ml of Mueller hinton broth was added to 10 sterilized tubes, and in the next step, after shaking, 0.5 ml diluted Medicago Sativa extract was added tube No.2, after shaking in tube No.2, 0.5 ml of the solution was transferred to tube No.3 and the process was repeated to tube No.9 and finally, 0.5 ml of the solution was discarded (the concentration of the first tube was 500 )mg / ml). After this step, according to the McFarland standards, 0.5 ml of the microbial suspension was added to all the tubes and were kept at 37 °C for 24 hours. Eventually, the first transparent tube with inhibited bacterial growth was considered MIC or the least concentration of growth inhibitor of the extract. To confirm a tube before the first transparent tube and the next tube was cultured on a chocolate agar medium. Each treatment had a positive (culture medium with bacteria of each strain) and negative (extract-free culture medium and a bacterium) control. In this test, the tube No.1 was negative and the tube No.10 was positive.
Determination disc diffusion
In order to test the Disc diffusion (DD), the bacteria were grown on Mueller hinton broth. Discs with diameter of 10 mm, impregnated with Medicago sativa root extract (MIC equivalent) were placed on the medium. After 24 hours of incubation at 37 ° C, the diameter of the inhibition zone was measured from the back of the plate with the ruler and the results were recorded (19) . Moreover, in the case of haemophilus influenza from the medium of Muller Hinton Broth with Growth factors (supplement) containing 3% of sheep blood lysis was used (20) .
Results
In this study, the effect of Medicago sativa root extract on standard strains of Streptococcus pneumoniae, Haemophilus influenza, Moraxella catarrhalis and Staphylococcus aureus was investigated. The results show that the MIC of Medicago sativa root extract against Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis was 125 mg / ml, that is, MIC of Medicago sativa roots extract at this concentration has an effect. The extract with the studied concentration and used method did not affect Staphylococcus aureus, and turbidity and growth were observed in all tubes (Table 1) . After determining the MIC for the bacteria in the vicinity of the Medicago sativa root extract, a disc diffusion test was laid. In the disc diffusion method, the diameter of the inhibition zone was 16 mm for Moraxella catarrhalis, 13 mm for Streptococcus pneumoniae and 10 mm for Haemophilus influenza and in the case of Staphylococcus aureus, no inhibition zone was found around the disc containing the extract, which confirms the results of the MIC method data (Table  1) . Discussion According to the results, the Medicago sativa root extract has a significant antibacterial effect on common bacteria in sinusitis and bronchitis including Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis, but has no effect on Staphylococcus aureus bacteria. One of the possible reasons for the lack of anti-bacterial effect of Medicago sativa roots on Staphylococcus aureus may be the weakness of the active antibacterial agent Medicago sativa extract on the bacteria. Another factor that may affect the antibacterial effects of an extract of a plant is the extraction method and solvent type (21) . Extracts with different methods and solvents from one plant can exhibit different antibacterial effects on a particular bacterium (22) . In a study by Chavan et al. performed in India in 2015, they examined the antibacterial effect of Medicago sativa extract. In this study, the antibacterial effects of Medicago sativa extract on E.coli and Pseudomonas aeruginosa were studied by MIC and disk diffusion methods. The results showed inhibitory and antibacterial effect of Medicago sativa extract on the bacterial growth (23) . In a study by George p et al., performed in India in 2014, the antibacterial effect of Medicago sativa extract on different bacteria such as Bacillus licheniformis, Pseudomonas aeruginosa, Lactococcus lactis, Klebsiella pneumonia, Bacillus cereus was investigated. In this study, MIC and disc diffusion methods were used to study the inhibitory effect of Medicago sativa plant extract. The results of this study, such as the previous study (Chavan et al.) , show the effectiveness of the anti-bacterial effect of Medicago sativa extract on the bacteria mentioned (10) . Various studies have shown that Medicago Sativa has antimicrobial activity against bacteria (24, 25) . Also, in a similar study carried out by Aliahmadi et al. in 2011, the effect of this extract on the elimination of bacteria was confirmed (26) . Certainly, in the ancient medicine, special attention was paid to the various functions of plant extracts based on the organs involved in a disease. Many plants have secondary metabolites, such as terpenes, alkaloids, glycosides, flavonoids, etc., of which secondary metabolites have the ability to fight against microorganisms (27) 
Conclusion
The results of this study indicate the inhibitory effect of Medicago Sativa root Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis. Plants can be considered as a source of potential chemical substances, only a part of which has been exploited. In future studies, researchers should separately investigate the effects of components in Medicago sativa roots extract in terms of antimicrobial effects. A clinical evaluation is also needed to find out that it can be used as a cheap substance and with low side effects to prevent and treat common infections, especially in cases where drug resistance and the risk of recurrent infections are high. The results of this study suggest that Medicago sativa root extract can be used alone or in combination with other antimicrobial agents to improve or treat sinusitis and bronchitis. With this and other studies, we can hope to develop a suitable drug for the treatment of sinusitis. However, it is needed to perform this study in invivo conditions to evaluate the probable toxicity of the extract due to the high levels of arsenic and silica (9) ,its properties and the appropriate concentrations of this extract for living organisms.
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